Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial...

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Stem Cell Biology

Background:

• Myocardial infarction (MI) leads to significant cardiac damage and functional decline.
• Adipose tissue-derived cells offer potential for cardiac repair but require comparative analysis.
• Understanding cell survival, differentiation, and mechanisms is crucial for therapeutic development.

Purpose of the Study:

• To compare the efficacy of freshly isolated adipose tissue-derived cells (fhADCs) and cultured adipose tissue-derived stem cells (hASCs) in treating myocardial infarction.
• To evaluate the long-term survival and integration of these cells within the infarcted cardiac tissue.
• To elucidate whether observed therapeutic effects stem from direct cell differentiation or paracrine signaling.

Main Methods:

• Myocardial infarction was induced in immunodeficient mice.
• Mice received injections of fhADCs, hASCs, or a control solution in the peri-infarct region.
• Cardiac function, cell survival (bioluminescence imaging), differentiation (immunofluorescence), vascularization, and apoptosis were assessed.

Main Results:

• Both fhADCs and hASCs significantly improved cardiac function 4 weeks post-MI.
• Injected cells expressed cardiomyogenic markers (connexin 43, troponin I) and integrated into host tissue and vasculature.
• Cells survived up to 4 months, with increased vascular density and reduced apoptosis in treated hearts.

Conclusions:

• This study provides the first systematic comparison of fhADCs and hASCs for myocardial regeneration.
• Both fhADCs and hASCs demonstrate engraftment, long-term survival, and functional improvement in infarcted hearts.
• fhADCs represent a promising alternative cell source for myocardial repair, similar to hASCs.